scholarly journals The 43rd Congress of Japanese Society for Dialysis Therapy International Symposium on Present status of medical care for ESRD in the developing Asian countries, Part II

1999 ◽  
Vol 32 (6) ◽  
pp. 951-952
Author(s):  
Taketoshi Kishimoto ◽  
Visith Sitprija
2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Toru Hyodo ◽  
Masafumi Fukagawa ◽  
Nobuhito Hirawa ◽  
Yoshitaka Isaka ◽  
Hidetomo Nakamoto ◽  
...  

AbstractSince 2015, the Committee of International Communication on Academic Research of the Japanese Society for Dialysis Therapy has held its Asian symposium during the society’s Annual Congress to discuss the present status of and demand for dialysis therapy in Asian countries. The aim of the symposium is to identify needs and find ways to contribute in the area of dialysis therapy in these countries. Three manuscripts are presented here by participants at the 2017 Asian symposium from Vietnam, Myanmar, and Cambodia.With economic development, hemodialysis (HD) therapy is now available worldwide. However, the cost of HD is very high compared with the average income in these three countries and, as of 2017, Cambodia and Myanmar have not yet established national health insurance systems. In Cambodia, patients must bear 100% of the cost for dialysis. In Myanmar, the government covers the cost of HD (20 USD, 40% of total cost) in public HD centers, but this service is still insufficient to meet current demand, with long waiting lists of up to 6 months at government HD centers. In contrast, in Vietnam, dialysis is almost completely covered by national health insurance. Dialyzers tend to be reused in all three countries. Continuous ambulatory peritoneal dialysis is available in Vietnam and Myanmar but not in Cambodia. Viable health insurance systems should be established as soon as possible in Cambodia and Myanmar, although this will ultimately depend on the countries’ level of economic development.


2015 ◽  
Vol 19 ◽  
pp. 67-92 ◽  
Author(s):  
Yuzo Watanabe ◽  
Hideki Kawanishi ◽  
Kazuyuki Suzuki ◽  
Shigeru Nakai ◽  
Kenji Tsuchida ◽  
...  

2012 ◽  
Vol 45 (7) ◽  
pp. 599-613 ◽  
Author(s):  
Shigeru Nakai ◽  
Kenji Wakai ◽  
Kunihiro Yamagata ◽  
Kunitoshi Iseki ◽  
Yoshiharu Tsubakihara

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Kazuyoshi Okada ◽  
Ken Tsuchiya ◽  
Ken Sakai ◽  
Takahiro Kuragano ◽  
Akiko Uchida ◽  
...  

Abstract Background In Japan, forgoing life-sustaining treatment to respect the will of patients at the terminal stage is not stipulated by law. According to the Guidelines for the Decision-Making Process in Terminal-Stage Healthcare published by the Ministry of Health, Labor and Welfare in 2007, the Japanese Society for Dialysis Therapy (JSDT) developed a proposal that was limited to patients at the terminal stage and did not explicitly cover patients with dementia. This proposal for the shared decision-making process regarding the initiation and continuation of maintenance hemodialysis was published in 2014. Methods and results In response to changes in social conditions, the JSDT revised the proposal in 2020 to provide guidance for the process by which the healthcare team can provide the best healthcare management and care with respect to the patient's will through advance care planning and shared decision making. For all patients with end-stage kidney disease, including those at the nonterminal stage and those with dementia, the decision-making process includes conservative kidney management. Conclusions The proposal is based on consensus rather than evidence-based clinical practice guidelines. The healthcare team is therefore not guaranteed to be legally exempt if the patient dies after the policies in the proposal are implemented and must respond appropriately at the discretion of each institution.


2014 ◽  
Vol 39 (5) ◽  
pp. 449-458 ◽  
Author(s):  
Junichi Hoshino ◽  
Kunihiro Yamagata ◽  
Shinichi Nishi ◽  
Shigeru Nakai ◽  
Ikuto Masakane ◽  
...  

1999 ◽  
Vol 37 (6) ◽  
pp. 1732-1738 ◽  
Author(s):  
Toshikazu Yamazaki ◽  
Hikaru Kume ◽  
Setsuko Murase ◽  
Eriko Yamashita ◽  
Mikio Arisawa

The data on visceral mycoses that had been reported in theAnnual of the Pathological Autopsy Cases in Japan from 1969 to 1994 by the Japanese Society of Pathology were analyzed epidemiologically. The frequency of visceral mycoses among the annual total number of pathological autopsy cases increased noticeably from 1.60% in 1969 to a peak of 4.66% in 1990. Among them, the incidences of candidiasis and aspergillosis increased the most. After 1990, however, the frequency of visceral mycoses decreased gradually. Until 1989, the predominant causative agent was Candida, followed in order by Aspergillus and Cryptococcus. Although the rate of candidiasis decreased by degrees from 1990, the rate of aspergillosis increased up to and then surpassed that of candidiasis in 1991. Leukemia was the major disease underlying the visceral mycoses, followed by solid cancers and other blood and hematopoietic system diseases. Severe mycotic infection has increased over the reported 25-year period, from 6.6% of the total visceral mycosis cases in 1969 to 71% in 1994. The reasons for this decrease of candidiasis combined with an increase of aspergillosis or of severe mycotic infection might be that (i) nonsevere (not disseminated) infections were excluded from the case totals, since they have become controllable by antifungal drugs such as fluconazole, but (ii) the available antifungal drugs were not efficacious against severe infections such as pulmonary aspergillosis, and (iii) the number of patients living longer in an immunocompromised state had increased because of developments in chemotherapy and progress in medical care.


2002 ◽  
Vol 22 (2) ◽  
pp. 243-248 ◽  
Author(s):  
Tao Wang ◽  
Georgi Abraham ◽  
Takashi Akiba ◽  
Peter Blake ◽  
Ram Gokal ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document